Rising Anemia Treatment Demand Drives Growth in the North America Erythropoietin Drug Sector
Rising awareness of chronic kidney disease and cancer-associated anemia across North America is encouraging demand for effective supportive therapies. Healthcare facilities are focusing on improving access to appropriate anemia management solutions. Market Overview The Erythropoietin Drug Market was valued at US$ 13.14 billion in 2025 and is projected to reach US$ 29.00 billion by 2034,...
0 Commentarii 0 Distribuiri 18 Views 0 previzualizare